Table 3: Factors related to the incidence of peripheral neuropathy.

FactorPeripheral neuropathy, N (%)
YesNoNot documented

Sex
 Male141 (43.8)40 (12.4)3 (0.9)
 Female109 (33.8)27 (8.4)2 (0.6)
Treatment regimen
 FOLFOX157 (48.8)49 (15.2)5 (1.5)
 XELOX89 (27.6)16 (4.9)0 (0)
FOLFOX + avastin1 (0.3)0 (0)0 (0)
Oxaliplatin alone3 (0.9)2 (0.6)0 (0)
Age in range (years)
 30–5037 (14.5)8 (2.5)0 (0)
 51–6044 (13.7)7 (2.2)0 (0)
 61–78146 (45.3)38 (11.8)4 (1.2)
 79–8823 (7.1)14 (4.3)1 (0.3)
Previous chemotherapy
 No235 (72.9)62 (19.3)5 (1.5)
 Yes15 (4.7)5 (15.6)0 (0)
Cancer
 Adjuvant181 (56)48 (14.9)4 (1.2)
 Metastatic69 (21.4)19 (5.9)1 (0.3)